For Dr. Carol Nacy, co-founder and CEO of Rockville, Maryland’s clinical-stage antibiotics developer Sequella, it all started with a fascination for things unseen.
{iframe}http://www.biobuzz.inloop.com/en/article/66082?utm_source=ElasticEmail-sb-biobizHub&utm_medium=newsletter&utm_campaign=biobizHub-401-s-en-060918{/iframe}